BANGALORE, Dec 2 (Reuters) - Takeda Pharmaceutical <4502.T> is looking to enter the fast-growing Indian drug market, but Japan's largest drugmaker is yet to decide whether it will do so on its own or ...
* Says it plans to transfer partial Takeda Development Center Japan business related to clinical trials, pharmacovigilance services for both development and marketed products which are operated by TDC ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する